Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL5557584

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
CC(=O)N1CCC(CCn2nc(-c3ccc4[nH]cc(C)c4c3)c3c(N)ncnc32)CC1

Basic Information

ChEMBL ID CHEMBL5557584
Phase Preclinical
Structure Type MOL
InChI Key HCGVOSYLBCMBNI-UHFFFAOYSA-N
3
Targets
3
Activities
2
Assay Types
19
PK Parameters
20
Publications
0
Known Names

Molecular Properties

417.5
MW (Da)
3.51
ALogP
6
HBA
2
HBD
105.7
PSA (Ų)
0.53
QED
0
Ro5 Violations
4
Rot. Bonds

Drug Information

Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C23H27N7O
MW 417.52
Aromatic Rings 4
Heavy Atoms 31
NP-Likeness -0.98

Activity Summary

IC50 2 meas. best 7.76
EC50 1 meas. best 7.82

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
TGF-beta receptor type-1
CHEMBL2021750
EC50 7.82 7.82 15.3 1
TGF-beta receptor type-1
CHEMBL4439
IC50 7.76 7.76 17.3 1
Voltage-gated inwardly rectifying potassium channel KCNH2
CHEMBL240
IC50 5.01 5.01 9870.0 1

Pharmacokinetic Data

Parameter Value Units Species
AUC 1931.0 ng.hr.mL-1 Rattus norvegicus
AUC 668.0 ng.hr.mL-1 Rattus norvegicus
AUC 3352.0 ng.hr.mL-1 Rattus norvegicus
CL 1049.0 ml/hr Rattus norvegicus
CL 3175.0 ml/hr Rattus norvegicus
CL 624.0 ml/hr Rattus norvegicus
Cmax 0.00314 ug.mL-1 Rattus norvegicus
Cmax 0.000546 ug.mL-1 Rattus norvegicus
Cmax 0.001926 ug.mL-1 Rattus norvegicus
F 11.5 % Rattus norvegicus
F 57.9 % Rattus norvegicus
MRT 0.798 hr Rattus norvegicus
MRT 1.29 hr Rattus norvegicus
MRT 2.34 hr Rattus norvegicus
T1/2 0.621 hr Rattus norvegicus
T1/2 0.962 hr Rattus norvegicus
T1/2 1.132 hr Rattus norvegicus
Tmax 0.583 hr Rattus norvegicus
Tmax 0.5 hr Rattus norvegicus

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
38626523 10.1016/j.ejmech.2024.116395 ADMET 23
38626523 10.1016/j.ejmech.2024.116395 Unchecked 8
38626523 10.1016/j.ejmech.2024.116395 NIH3T3 4
38626523 10.1016/j.ejmech.2024.116395 Panc02 4
38626523 10.1016/j.ejmech.2024.116395 PANC-1 4
38626523 10.1016/j.ejmech.2024.116395 TGF-beta receptor type-1 4
38626523 10.1016/j.ejmech.2024.116395 4T1 1
38626523 10.1016/j.ejmech.2024.116395 HEK-293T 1
38626523 10.1016/j.ejmech.2024.116395 BEAS-2B 1
38626523 10.1016/j.ejmech.2024.116395 MV4-11 1
38626523 10.1016/j.ejmech.2024.116395 Kasumi 1 1
38626523 10.1016/j.ejmech.2024.116395 U-251 1
38626523 10.1016/j.ejmech.2024.116395 HepG2 1
38626523 10.1016/j.ejmech.2024.116395 MDA-MB-231 1
38626523 10.1016/j.ejmech.2024.116395 Vascular endothelial growth factor receptor 2 1
38626523 10.1016/j.ejmech.2024.116395 Epidermal growth factor receptor 1
38626523 10.1016/j.ejmech.2024.116395 Platelet-derived growth factor receptor alpha 1
38626523 10.1016/j.ejmech.2024.116395 Proto-oncogene tyrosine-protein kinase receptor Ret 1
38626523 10.1016/j.ejmech.2024.116395 Serine/threonine-protein kinase B-raf 1
38626523 10.1016/j.ejmech.2024.116395 Tyrosine-protein kinase Lck 1

Data from ChEMBL 36 via Core Engine